HOME >> BIOLOGY >> NEWS
High Testosterone Level May Lead Male Junco To Stray From Mate

COLUMBUS, Ohio -- What makes a normally monogamous male bird stray from his mate to copulate with neighboring females?

High levels of testosterone may be part of the answer, according to a new study. Researchers found that male dark-eyed juncos that were given extra testosterone during the breeding season were more likely than normal males to fertilize females other than their mates.

The junco’s family at the home nest paid the price for these sexual encounters. Results showed that high-testosterone male juncos spent less time providing care for young in their own nests. Researchers suspect this is why high-testosterone males, when compared to normal males, produced fewer offspring with their own mates but more offspring with the mates of their neighbors.

The study was conducted by Samrrah Raouf, a graduate student, and biologists Ellen Ketterson and Val Nolan, the project’s directors, all of Indiana University. They collaborated with Patricia Parker, associate professor of zoology at Ohio State University, who is an expert in mating systems of birds and in determining parentage; and Charles Ziegenfus of James Madison University, who has studied juncos for many years. Their findings were published in a recent issue of the Proceedings of the Royal Society of London Series B - Biological Sciences.

“Researchers all over the world are using new genetic tools like DNA fingerprinting to understand animal mating behavior,” Parker said.

“In many cases, the results reveal that clandestine matings are taking place, but we often know little about the conditions under which they take place, or the costs and benefits of different mating tactics,” Parker explained.

“This study suggests testosterone plays an important role in determining how often males wander from their home nests to fertilize other females,
'"/>

Contact: Patricia Parker
Parker.3@osu.edu
(614) 292-0378
Ohio State University
10-Feb-1998


Page: 1 2 3 4

Related biology news :

1. Testosterone levels and marriage: High is not all bad
2. Testosterone gel (AndroGel) study demonstrates safety and efficacy up to 42 months
3. Testosterone dose-repsonse relationships in healthy young men
4. Testosterone, stress may not suppress immune system after all
5. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
6. Stress Lowers Sperm Count By Overwhelming Cells That Make Testosterone
7. Testosterone And Working Memory; Epilepsy And Schizophrenia; Toxins And Neuron Death; Oregon Researchers Present Findings At Society For Neuroscience
8. The Reason The French Have Low Levels Of Heart Disease
9. Marine Life In South Pacific Region Found To Be Impervious To Oceans Highest Arsenic Levels
10. Breast Milk Of Women Who Eat Lake Ontario Fish Contains High Levels Of PCBs, UB Study Finds
11. For First Time In 40 Years National Jewish Researchers Report Chronic Beryllium Disease Caused By Extremely Low Levels Of Exposure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Testosterone Level May Lead Male Junco Stray From Mate

(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: